Eastman Board Elects New Director

Dr. Mink is Chairman, President and Chief Executive Officer of Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional functional ingredients, with applications in food, health and industrial specialties markets.

“We are pleased to welcome Kim Ann to Eastman’s Board of Directors. Having spent the majority of her career in specialty materials, Kim Ann brings invaluable experience and technical expertise to Eastman,” said Mark Costa, Board Chair and CEO. “Her proven leadership and deep understanding of key end markets will enhance our Board’s continued direction of our innovation-driven growth strategy as an outperforming specialty company.”

Dr. Mink, 58, joined Innophos in 2015 from the Dow Chemical Company where she served most recently as business president of Elastomers, Electrical and Telecommunications. Prior to joining Dow Chemical in 2009, she had previously served for more than 20 years at the Rohm and Haas Company (which was acquired by Dow Chemical) where she held roles of increasing responsibility, including corporate vice president and general manager for the Ion Exchange Resins business.

Dr. Mink received a bachelor's degree in Chemistry from Hamilton College and a Ph.D. in Analytical Chemistry from Duke University. She is a graduate of the Management Program at the Wharton School of the University of Pennsylvania.